Ann: Cantrixil last patient visit, page-12

Yes rikki, a truly remarkable result for Cantrixil and a way forward for the many women who suffer from this terrible cancer.
A complete recovery with one patient is validation of the science and hard work from Novogen and Yale scientists and researchers.
Associate Professor Jermaine Coward is a very caring and dedicated lead investigator responsible for our trial.
The upcoming Kazia SPP will be well supported and most likely over subscibed by the retail shareholders @ $0.40 per share.

Regards.